Skip to content

BridgeBio vs Takeda

BridgeBio logo

BridgeBio

We move at the speed of patient need

875 employees · est. 2014 · Palo Alto, United States

VS
Takeda logo

Takeda

Better Health, Brighter Future

37130 employees · est. 1781 · Tokyo, Japan

Takeda is the older company (2014 vs 1781); Takeda is the larger of the two.

Side-by-Side Comparison

BridgeBio Takeda
Founded
2014 1781 older
Headquarters
Palo Alto, United States Tokyo, Japan
Employees
875 37130 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Pharmaceutical
Funding Stage
Post-IPO Equity IPO
Total Funding
$3.85B $57.80M
Funding Rounds
13 3
Services
drug research and development, clinical trials and testing, regulatory submissions, patient support and advocacy, scientific publications and presentations Drug Development, Clinical Trials, Manufacturing, Corporate Governance, Ethics and Transparency
Target Customers
patients with rare genetic conditions, healthcare providers, medical researchers, pharmacists, biotechnology investors Patients with Chronic Diseases, Healthcare Providers, Investors, Global Healthcare Markets
Taxonomy
Genetic MedicineGenetic Disease TherapiesR&D SupportTransformative MedicinesEntrepreneurial ApproachPatient-centric Innovation +8 Transformative HealthcarePatient-centered ApproachInnovative MedicinePharmaceutical ResearchHealthcare SolutionsValues-driven +6
Website
bridgebio.com takeda.com
BridgeBio logo

About BridgeBio

BridgeBio, founded in 2014, is a U.S.-based biotech company focused on delivering transformative medicines for genetic conditions, seeking to align genetic and entrepreneurial advances. Their slogan, "We move at the speed of patient need," encapsulates their mission to address urgent patient require...

Takeda logo

About Takeda

Takeda, headquartered in Japan, is a historic player in the Biotechnology and Pharmaceutical industries, embodying more than two centuries of commitment to patient-centric healthcare solutions. Their slogan, "Better Health, Brighter Future," reflects their enduring mission to transform lives by prio...

Also comparing in this category

Comparing more than these two?

Get BridgeBio, Takeda and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does BridgeBio compare?

A PDF of BridgeBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

BridgeBio was founded in 2014, based in Palo Alto, United States, with 875 employees. BridgeBio, founded in 2014, is a U.S.-based biotech company focused on delivering transformative medicines for genetic conditions, seeking to align genetic and entrepreneurial advances. Their slogan,. Takeda was founded in 1781, based in Tokyo, Japan, with 37,130 employees. Takeda, headquartered in Japan, is a historic player in the Biotechnology and Pharmaceutical industries, embodying more than two centuries of commitment to patient-centric healthcare solutions. Their.
BridgeBio has raised $3.85B and Takeda $57.80M. Latest stage: BridgeBio Post-IPO Equity, Takeda IPO.
Both work in Biotechnology and Pharmaceutical and list scientific advancement among their focus areas.

Compare BridgeBio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BridgeBio on 11 Mar 2026, and Takeda on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout